Difference between revisions of "Part:BBa K5375007"
(→Cultivation and Purification) |
|||
Line 35: | Line 35: | ||
<span id="cultivation-purification"></span> | <span id="cultivation-purification"></span> | ||
= Cultivation and Purification = | = Cultivation and Purification = | ||
+ | The part sequence we have registered is its corresponding DNA sequence, which needs to be transcribed into RNA sequence for use. The following sequences are siRNA sequences. | ||
siHSP70-2 is synthesized through oligonucleotides with a nucleic acid synthesizer. The following sequences represent the sense and antisense strands of the siRNA: | siHSP70-2 is synthesized through oligonucleotides with a nucleic acid synthesizer. The following sequences represent the sense and antisense strands of the siRNA: | ||
- Oligo Sequence for siHSP70-2-SS: CCUACGGUCUUGACAAGAAGC | - Oligo Sequence for siHSP70-2-SS: CCUACGGUCUUGACAAGAAGC | ||
+ | |||
- Oligo Sequence for siHSP70-2-AS: UUCUUGUCAAGACCGUAGGCA | - Oligo Sequence for siHSP70-2-AS: UUCUUGUCAAGACCGUAGGCA | ||
Line 44: | Line 46: | ||
<span id="measurement-characterization"></span> | <span id="measurement-characterization"></span> | ||
+ | |||
= Measurement and Characterization = | = Measurement and Characterization = | ||
Revision as of 07:48, 30 September 2024
siHSP70-2
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Contents
Origin
Synthesized by company.
Properties
Inhibition of Heat Shock Protein 70 expression.
Usage and Biology
siHSP70-2 inhibits the target gene HSP70 as a small interfering RNA (siRNA). HSP70 can induce IgE-mediated hypersensitivity reactions and T-cell responses in allergic individuals (Fagotti et al., 2022). Further discussion of it as a pan-allergen can be found in part BBa_K2619011. siRNA is a key component of the RNAi process, a powerful gene silencing mechanism. Once introduced into the target cells, it is recognized and loaded into the RNA-Induced Silencing Complex (RISC). The siRNA’s antisense strand binds to the complementary target mRNA molecule, triggering the RISC complex to cleave the target mRNA. This prevents the mRNA from being translated into a functional protein (Agrawal et al., 2003). The silencing effect typically lasts around 12 days for this part.
siHSP70-2 is particularly useful in plant cells, where it successfully inhibits the expression of the pan-allergen HSP70, reducing allergic symptoms related to *Populus tomentosa* pollen allergy.
Cultivation and Purification
The part sequence we have registered is its corresponding DNA sequence, which needs to be transcribed into RNA sequence for use. The following sequences are siRNA sequences.
siHSP70-2 is synthesized through oligonucleotides with a nucleic acid synthesizer. The following sequences represent the sense and antisense strands of the siRNA:
- Oligo Sequence for siHSP70-2-SS: CCUACGGUCUUGACAAGAAGC
- Oligo Sequence for siHSP70-2-AS: UUCUUGUCAAGACCGUAGGCA
These oligonucleotides are then annealed to form a double-stranded siRNA molecule. The siRNA is purified using high-performance liquid chromatography (HPLC) (Sohail et al., 2003). To enhance delivery into plant cells, carbon dots (CDs) were incorporated with Polyethyleneimine (PEI) through the microwave method, which allowed the negatively charged siRNA to bind to the CDs.
Measurement and Characterization
The chart demonstrates the performance of siHSP70-2 in inhibiting HSP70 expression. Results indicate that siHSP70-2 successfully repressed HSP70 expression, reducing it to less than 20% of its original level.
RT-qPCR results for siRNA injection in tobacco leaves. While siHSP70-2 showed some success in repressing HSP70 expression after combination with CDs, it was less efficient compared to siHSP70-3.
RT-qPCR results for siRNA delivery through trunk injection in osmanthus trees. Some success was observed in inhibiting HSP70 expression with the combination of CDs, but the efficacy was not as high as that of CDs@siHSP70-3.
Further trials and improvements are needed for siHSP70-2 to ensure optimal quality and efficiency in target gene repression.
Reference
Agrawal N. N., Dasaradhi P. V., Mohmmed A., Malhotra P., Bhatnagar R. K., & Mukherjee S. K. (2003). RNA Interference: Biology, Mechanism, and Applications. *Microbiology and Molecular Biology Reviews*, 67(4), 657-685. [1](https://doi.org/10.1128/MMBR.67.4.657-685.2003)
Fagotti A., Lucentini L., Simoncelli F., La Porta G., Brustenga L., Bizzarri I., Trio S., Isidori C., Di Rosa I., & Di Cara G. (2022). HSP70 upregulation in nasal mucosa of symptomatic children with allergic rhinitis and potential risk of asthma development. *Scientific Reports*, 12(1), 1-10. [2](https://doi.org/10.1038/s41598-022-18443-x)
Sohail M., Doran G., Riedemann J., Macaulay V., & Southern E. M. (2003). A simple and cost-effective method for producing small interfering RNAs with high efficacy. *Nucleic Acids Research*, 31(7), e38.